医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Omniscience Technology Chosen by Major Japanese Life Insurance Company

2020年07月09日 PM10:42
このエントリーをはてなブックマークに追加


 

PALO ALTO, Calif.

Omniscience today disclosed that Sompo Himawari Life Insurance Company has adopted Omniscience artificial intelligence (AI) technology as part of a new consumer service. This Omniscience technology is an important onramp for Computational Insurance™.

“An entirely new business model is needed for the insurance industry which faces challenges and stresses from more directions than ever before,” said Pallavi Ramnarain, Omniscience Vice President of Business Development & Strategy. “The ability to use, verify, and manipulate every piece of information digitally is an important element of Computational Insurance.”

The Omniscience AI being used by the newly announced Sompo Himawari Linkx Health Tri service provides the ability to retrieve Japanese language health screening data from images – giving Sompo Himawari a way to better understand its customers. This Omniscience capability complements its systematic suite of Computational Insurance products and technologies currently being launched by the company.

“We are very proud to be working with Sompo Himawari in Japan,” said Sakuya Morimoto, Omniscience Vice President for Japan.

About Omniscience

Omniscience (www.omniscience.com) is the first company to enable the Computational Insurance™ business. Because of unique breakthrough distributed technology that can process many layers of business and data complexity completely and rapidly, Omniscience customers can approach their businesses in entirely new ways. Instead of this complexity inhibiting good decisions, insurance customers can use the vast amounts of data from inside and outside sources to make good business decisions that continuously improve the entire company while increasing transactional speed. Ultimately, Omniscience Computational Insurance solutions optimize insurance and financial services companies grow market share, save on costs, boost return on equity, and increase regulatory compliance. Over time many additional Computational Enterprise™ markets will benefit from Omniscience to handle the chaos in their environments. Based in Palo Alto, CA, investors in Omniscience include Guardian Life Insurance Company of America, TD Bank, Translink Capital, and others.

All trademarks and registered trademarks are those of their respective companies.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200709005623/en/

CONTACT

For more press information contact:

Abigail Johnson

Roeder-Johnson Corporation

650-395-7078

http://email.roeder-johnson.com

For more customer information contact:

Omniscience Corporation

info@omniscience.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Seoul Viosys’ Violeds Modules Proven to Disinfect 99% of Airborne Viruses in a Recent Testing Result
  • Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan
  • Kaye推出适用于冷链运输市场的Kaye® Log -80℃ 疫苗温度记录器,以满足COVID-19疫苗储存和运输的要求
  • Kaye® (ケイ)は、COVID-19ワクチンの輸送・保管のニーズに応えるためにKaye® ログ -80ワクチン温度ロガーを、コールドチェーン市場向けに導入(発売)します。
  • DNP的新型非接触式透明屏幕可通过手的动作进行操作